Tissue engineering applications in the management of bone loss

Clinical Cases in Mineral and Bone Metabolism

Volumn 10, Issue 1, 2013, Pages 22-25

  Carulli, Christian ^a   Matassi, Fabrizio ^a   Civinini, Roberto ^a   Innocenti, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bone graft; Bone loss; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN; TISSUE SCAFFOLD;

BONE DEFECT; BONE DEVELOPMENT; BONE IMPLANT; BONE MATRIX; BONE METABOLISM; BONE REGENERATION; HUMAN; HUMAN TISSUE; OSTEOLYSIS; REVIEW; TISSUE ENGINEERING;

EID: 84878324653     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/ccmbm/2013.10.1.022     Document Type: Review

References (16)

1. Kneser U, Schaefer DJ, Munder B, Klemt C, Andree C, Stark GB. Tissue engineering of bone. Minimally Invasive Therapy & Allied Technologies 2002; 11(3): 107-116.
2. Hernigou P, Homma Y. Tissue bioengineering in orthopedics. Clin Cases Mineral Bone Met 2012; 9: 21-23.
3. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Medicine 2011;9: 66-75.
4. Van Loon CJ, de Waal Malefijt MC, Verdonschot N, et al. Moresllised bone grafting compensates for femoral bone loss in revision total knee arthroplasty: an experimental study. Biomaterials 1999;20: 85-9.
5. Van Loon CJ, de Waal Malefijt MC, Buma P, et al.Autologous morsellised bone grafting restores uncontained femoral bone defects in knee arthroplasty: an in vivo study in horses. J Bone Joint Surg Br 2000;82: 436-44.
6. Lotke PA, Wong RY, Ecker ML. The use of methylmethacrylate in primary total knee replacements with large tibial defects. Clin Orthop Relat Res 1991;270: 288-94.
7. Radnay CS, Scuderi GR. Management ob bone loss: augments, cones, offset stems. Clin Orthop Relat Res 2006;446: 83-92.
8. Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 2001;382: 42-50.
9. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005;87: 1430-7.
10. Jäger M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C, Hendrich C, Krauspe R. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011;29: 173-80.
11. Urist MR. Bone: formation by autoinduction. Science 1965-12;150: 893-9.
12. D'Antonio JA. Periprosthetic bone loss of the acetabulum. Classification and management. Orthop Clin North Am 1992;23: 279-90.
13. Steinberg ME, Brighton CT, Corces A, Hayken GD, Steinberg DR, Strafford B, Tooze SE, Fallon M. Osteonecrosis of the femoral head. Results of core decompression and grafting with and without electrical stimulation. Clin Orthop Relat Res 1989;249: 199-208.
14. Civinini R, De Biase P, Carulli C, Matassi F, Nistri L, Capanna R, Innocenti M. The use of an injectable calcium sulphate/calcium phosphate bioceramic in the treatment of osteonecrosis of the femoral head. Int Orthop 2012;36: 1583-8.
15. Ruedi TP, Buckley RE, Moran CG. AO Principles of Fracture Management. Thieme Editor, 2006.
16. Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 2006;88-Suppl 1: 322-7.